36 / 64
34
POSTERS
| PROGRAMME & EXHIBITION GUIDE
EGFR detection in saliva as an easy diagnostic and prognostic tool in oral
squamous cell cancer
C. Piazza (Italy), A. Paderno, L. Zanotti, E. Bandiera, F. Del Bon, C. Romani,
P. Perotti, E. Bignotti, N. Montalto, R. Morello, F.E. Odicino, P. Nicolai,
A. Ravaggi
PO-102
Oropharyngeal cancer patient-derived xenografts: characterisation and
radiosensitivity.
J. Lilja-Fischer (Denmark), B. Ulhøi, J. Alsner, P. Lassen, V. Nielsen,
J. Overgaard
PO-103
Everolimus in oral cancer: a potential therapeutic approach dependent on
cell type?
C. Domingues (Portugal), P. Matafome, S. Neves, M. Laranjo, R. Seiça,
M.F. Botelho, A.B. Sarmento-Ribeiro, M. Dourado
PO-104
Is there justification for age bias in HPV p16 testing for oropharyngeal
squamous cell carcinoma?
S. McCauley (UK), P. McCloskey, C. Lyons, K. Brown, K. Rooney,
F. Houghton
PO-105
Prognostic significance of cyclin D1 and pRb expression in oropharyngeal
carcinoma
M.A. Broglie (Switzerland), M.M. Plath, S.J. Stoeckli, W. Jochum
PO-106
Clinical outcomes of HPV-positive non-oropharyngeal squamous cell
carcinoma: analysis of the NCDB
H. Ko (USA), R. Sacotte, M. Yu, S. Chen, A. Wieland, M. Witek
PO-107
TLR induced PDL-1 expression in HNSCC as a potential tool of
immunomodulation
B. Wollenberg (Germany), R. Pries, M. Drenckhahn, K. Ploetze-Martin,
B. Wollmann
PO-108